Teva Pharmaceutical Industries (TEVJF) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to -$3.6 billion.
- Teva Pharmaceutical Industries' Enterprise Value fell 2013.51% to -$3.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.6 billion, marking a year-over-year decrease of 2013.51%. This contributed to the annual value of -$3.6 billion for FY2025, which is 2013.51% down from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Enterprise Value stood at -$3.6 billion for Q4 2025, which was down 2013.51% from -$2.2 billion recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Enterprise Value ranged from a high of -$768.0 million in Q1 2021 and a low of -$3.6 billion during Q4 2025
- Over the past 5 years, Teva Pharmaceutical Industries' median Enterprise Value value was -$1.8 billion (recorded in 2022), while the average stood at -$1.9 billion.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Enterprise Value crashed by 9583.33% in 2024 and then skyrocketed by 3800.44% in 2025.
- Teva Pharmaceutical Industries' Enterprise Value (Quarter) stood at -$1.2 billion in 2021, then crashed by 67.39% to -$2.0 billion in 2022, then dropped by 29.85% to -$2.6 billion in 2023, then fell by 13.58% to -$3.0 billion in 2024, then dropped by 20.14% to -$3.6 billion in 2025.
- Its Enterprise Value was -$3.6 billion in Q4 2025, compared to -$2.2 billion in Q3 2025 and -$2.2 billion in Q2 2025.